Table 3. Drug-induced T2DM risk ranking of beta-blockers based on medical information from [58, 61–66] and GUT-DOCK results.
| Name | Rank based on medical information | Rank based on medical information combined with GUT-DOCK results |
|---|---|---|
| compound 15 | No data available yet | 0 |
| nebivolol* | 1 | 1 |
| carvedilol | 1 | 2 |
| labetalol | 2 | 3 |
| atenolol | 3 | 4 |
| metoprolol | 4 | 5 |
* In a very recent clinical trial [67] carvedilol and nebivolol was assigned similar ranks, yet we believe that additional medical information should be gathered on that matter in the future.